Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mastocytosis, Systemic
|
11 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.800 | 0.987 | 76 | 1998 | 2020 | ||||||
MASTOCYTOSIS, SYSTEMIC, SOMATIC
|
1 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.700 | 0 | |||||||||
Mastocytosis
|
8 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.100 | 0.967 | 30 | 1995 | 2020 | ||||||
Leukemia, Mast-Cell
|
7 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.100 | 1.000 | 12 | 2004 | 2019 | ||||||
Neoplasms
|
1644 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.100 | 1.000 | 12 | 2005 | 2018 | ||||||
Leukemia, Myelocytic, Acute
|
6892 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.100 | 1.000 | 11 | 1998 | 2019 | ||||||
Indolent Systemic Mastocytosis
|
2 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.100 | 0.900 | 10 | 2002 | 2020 | ||||||
Childhood Leukemia
|
140 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.040 | 1.000 | 4 | 2007 | 2018 | ||||||
leukemia
|
144 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.040 | 1.000 | 4 | 2007 | 2018 | ||||||
Core binding factor acute myeloid leukemia
|
3 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.030 | 1.000 | 3 | 2012 | 2019 | ||||||
Cutaneous Mastocytosis
|
18 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.030 | 1.000 | 3 | 1999 | 2018 | ||||||
Aggressive Systemic Mastocytosis
|
2 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||||
Chronic eosinophilic leukemia
|
9 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2007 | 2012 | ||||||
Eosinophilia
|
23 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2007 | 2015 | ||||||
Eosinophilic disorder
|
22 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2007 | 2015 | ||||||
Gastrointestinal Stromal Tumors
|
154 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2007 | 2014 | ||||||
Hematological Disease
|
16 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.020 | 1.000 | 2 | 1995 | 2017 | ||||||
Malignant Neoplasms
|
1641 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.020 | 0.500 | 2 | 2006 | 2006 | ||||||
MYELODYSPLASTIC SYNDROME
|
95 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2005 | 2013 | ||||||
Skin lesion
|
52 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||||
Acute lymphocytic leukemia
|
222 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Adult Myelodysplastic Syndrome
|
20 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||
Aleukemic mast cell leukemia
|
2 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
anaphylaxis
|
4 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Benign Mastocytoma
|
4 | 0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 |